Filtros de búsqueda

Lista de obras de Adam S. Cheifetz

A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.

artículo científico publicado en 2016

A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease

artículo científico publicado en 2017

A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study.

artículo científico publicado en 2013

A rare case series of concomitant inflammatory bowel disease, sporadic adenomas, and serrated polyposis syndrome.

artículo científico publicado en 2014

Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapy

artículo científico publicado en 2011

Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis

artículo científico publicado en 2015

An appraisal of the current state of gastroenterology practice guidelines

artículo científico publicado en 2013

Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date

artículo científico publicado en 2006

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2019

Appropriateness of Combination Therapy in Inflammatory Bowel Disease: One Size Still Does Not Fit All.

artículo científico publicado en 2018

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

artículo científico publicado en 2016

Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's Disease

artículo científico publicado en 2018

Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBD.

artículo científico publicado en 2014

Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis

artículo científico publicado en 2014

Biologic concentration testing in inflammatory bowel disease

artículo científico publicado en 2015

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies.

artículo científico publicado en 2018

Bone of Contention: Helicobacter pylori and Osteoporosis-Is There an Association?

artículo científico publicado en 2019

C-reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximab.

artículo científico publicado en 2017

CD39 and CD161 modulate Th17 responses in Crohn's disease

artículo científico publicado en 2014

CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease

artículo científico publicado en 2012

Capsule endoscopy for small-bowel evaluation in Crohn's disease

artículo científico publicado en 2011

Capsule endoscopy in suspected Crohn's disease: "yield" does not equal "diagnosis"

artículo científico publicado en 2010

Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis

scientific article published on April 2014

Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease

artículo científico publicado en 2014

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay

artículo científico publicado en 2020

Colonoscopy is appropriately utilized in most cases following a fair bowel prep

artículo científico publicado en 2014

Combined oral and topical mesalazine treatment for extensive ulcerative colitis

artículo científico publicado en 2006

Commentary: irritable bowel syndrome and the CDAI--misleading activity by straw men; authors' reply

scientific article published on 01 May 2013

Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease

artículo científico publicado en 2011

Comparative effectiveness research in inflammatory bowel disease: prospects and challenges

artículo científico publicado en 2012

Comparison between assays used for therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease

scientific article published on 05 March 2020

Crohn Disease: Epidemiology, Diagnosis, and Management

artículo científico publicado en 2017

Cryptosporidiosis masquerading as a Crohn's flare

artículo científico publicado en 2011

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

artículo científico publicado en 2008

Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis ⬇️

artículo científico publicado el 1 de febrero de 2011

Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer

artículo científico publicado en 2011

Documented compliance with inflammatory bowel disease quality measures is poor.

artículo científico publicado en 2014

Editorial: early post-induction anti-TNF drug monitoring can predict long-term therapeutic outcomes in inflammatory bowel disease.

artículo científico publicado en 2018

Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry

scientific article published on 01 September 2019

Editorial: therapeutic de-escalation of anti-tumour necrosis factor therapy - is less enough?

artículo científico publicado en 2017

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials

artículo científico

Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals

artículo científico publicado en 2013

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

artículo científico publicado en 2018

Endogenous antisense RNA curbs CD39 expression in Crohn's disease

scientific article published on 18 November 2020

Evaluation of the small bowel in inflammatory bowel disease.

artículo científico

Evidence Supporting High-Dose Use of Biologics in Clinical Practice

artículo científico

Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease.

artículo científico publicado en 2017

Factors Associated with the Success of In Vitro Fertilization in Women with Inflammatory Bowel Disease.

artículo científico publicado en 2016

Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease

artículo científico publicado en 2013

Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease

artículo científico publicado en 2018

Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease

artículo científico publicado en 2018

Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.

artículo científico publicado en 2015

Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression

artículo científico publicado en 2016

Hickam's dictum in a patient with diarrhea

artículo científico publicado en 2013

High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease

artículo científico publicado en 2014

Higher Adalimumab Drug Levels Are Associated with Mucosal Healing in Patients with Crohn's Disease.

artículo científico publicado en 2016

Histologic markers of inflammation in patients with ulcerative colitis in clinical remission

artículo científico publicado en 2013

Histological healing beyond endoscopic healing in ulcerative colitis: Shall we target the "ultra-deep" remission?

artículo científico publicado en 2017

Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.

artículo científico publicado en 2016

How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?

artículo científico publicado en 2008

How to Develop the Medical Neighborhood

artículo científico publicado en 2016

Immune-mediated reactions to anti-tumor necrosis factors in inflammatory bowel disease

artículo científico

Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective study

artículo científico publicado en 2009

Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis

artículo científico publicado en 2012

Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.

artículo científico publicado en 2009

Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab.

artículo científico publicado en 2017

In Vitro Fertilization Is Successful in Women With Ulcerative Colitis and Ileal Pouch Anal Anastomosis

artículo científico publicado en 2014

In reply--Clinical practice guidelines: still miles to go...

scientific article published on 01 June 2014

Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.

artículo científico publicado en 2017

Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts

artículo científico publicado en 2016

Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study

artículo científico publicado en 2019

Infliximab decreases colectomy rates in moderate to severe ulcerative colitis: big news or big deal?

scientific article published on 04 November 2010

Infliximab in inflammatory bowel disease

artículo científico publicado en 2019

Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis.

artículo científico publicado en 2017

Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy

scientific article published on 01 June 2019

Interventions for prevention of post-operative recurrence of Crohn's disease

artículo científico publicado en 2009

Interventions for prevention of post-operative recurrence of Crohn's disease

artículo científico publicado en 2008

In Vitro Fertilization in Women With Inflammatory Bowel Disease Is as Successful as in Women From the General Infertility Population

artículo científico publicado en 2015

Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?

artículo científico publicado en 2019

It Is Time to Treat to Trough: Staying Ahead of the Curve in Biologic Testing.

artículo científico publicado en 2015

Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes

artículo científico publicado en 2013

Letter: inflammatory bowel disease guidelines and conflicts of interest--authors' reply

artículo científico publicado en 2013

Letter: infliximab concentrations during induction therapy-one size does not fit all

artículo científico publicado en 2018

Letter: international IBD practice guidelines -- authors' reply.

artículo científico publicado en 2013

Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2018

Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease

scientific article published on 13 July 2018

Management of acute severe ulcerative colitis

artículo científico publicado en 2009

Melanin-concentrating hormone as a mediator of intestinal inflammation.

artículo científico publicado en 2008

Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer

artículo científico publicado en 2020

Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer

artículo científico publicado en 2019

Meta-analysis of the placebo response in ulcerative colitis

artículo científico publicado en 2007

Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease.

artículo científico publicado en 2010

Miscellaneous adverse events with biologic agents (excludes infection and malignancy).

artículo científico publicado en 2014

Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab

artículo científico publicado en 2012

New role for azathioprine in case of switching anti-TNFs in IBD

artículo científico publicado en 2020

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

artículo científico publicado en 2012

Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease

artículo científico

Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivation

artículo científico publicado en 2018

Poor Documentation of Inflammatory Bowel Disease Quality Measures in Academic, Community, and Private Practice

artículo científico publicado en 2015

Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission

artículo científico publicado en 2013

Prevalence and lifetime risk of endoscopy-related complications among patients with inflammatory bowel disease

artículo científico publicado en 2013

Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease

scientific article published on 01 August 2019

Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort

scientific article published on 01 January 2020

Proactive adalimumab monitoring in inflammatory bowel disease: current data and future perspectives

artículo científico publicado en 2019

Proactive infliximab monitoring following reactive testing is associated with better clinical outcomes than reactive testing alone in patients with inflammatory bowel disease.

artículo científico publicado en 2018

Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study

artículo científico publicado en 2014

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

artículo científico

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.

artículo científico publicado en 2016

Reducing the torment of diarrhea: tormentil for active ulcerative colitis

scientific article published on 01 October 2007

Reply

artículo científico publicado en 2017

Reply

Reply to Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department

artículo científico publicado en 2015

Response

artículo científico publicado en 2020

Response to Reinink

artículo científico publicado en 2017

Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic

artículo científico publicado en 2020

Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy

artículo científico publicado en 2011

Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.

artículo científico

Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days

artículo científico publicado en 2015

Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus

artículo científico publicado en 2016

Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelines

artículo científico publicado en 2015

Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in gastroenterology practice guidelines

artículo científico publicado en 2013

Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines

artículo científico publicado en 2014

Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis

artículo científico publicado en 2016

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease

artículo científico

Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines

artículo científico publicado en 2013

Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice

artículo científico publicado en 2017

Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?

artículo científico publicado en 2009

The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

scientific article published on 21 February 2013

The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis

scientific article published on 01 September 2019

The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation

article

The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy

scientific article published on 01 May 2019

The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease

scientific article published on 01 July 2018

The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.

artículo científico publicado en 2010

The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model

artículo científico publicado en 2014

The holistic effects of cannabis in Crohn's disease

artículo científico publicado en 2013

The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease

artículo científico publicado en 2008

The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease

artículo científico publicado en 2006

The role of mucosal healing in the treatment of patients with inflammatory bowel disease

artículo científico publicado en 2014

The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis.

artículo científico

The utility of capsule endoscopy in patients with suspected Crohn's disease

artículo científico publicado en 2009

Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window

artículo científico publicado en 2017

Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

artículo científico publicado en 2020

Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy.

artículo científico publicado en 2017

Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?

scientific article published on 09 April 2019

Thyroid cancer and Crohn's disease: association or coincidence?

artículo científico publicado en 2006

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

scientific article published on 10 September 2018

Ulcerative colitis: epidemiology, diagnosis, and management

artículo científico

Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.

artículo científico publicado en 2007

Use of anti-TNF drug levels to optimise patient management

artículo científico

Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

artículo científico publicado en 2018

Utility of CT in the emergency department in patients with ulcerative colitis

artículo científico publicado en 2015

Utility of Emergency Department Use of Abdominal Pelvic Computed Tomography in the Management of Crohn's Disease

artículo científico publicado en 2016

Vaccination in Inflammatory Bowel Disease ⬇️

artículo científico publicado el 1 de enero de 2011

Varicella zoster meningoradiculitis in Crohn's disease treated with 6-mercaptopurine

artículo científico publicado en 2011

Varicella zoster virus infection in inflammatory bowel disease

artículo científico

Varicella zoster virus infection in patients with inflammatory bowel disease

artículo científico

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease

artículo científico publicado en 2020

Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda